Butterfly Network Partners with Midjourney Medical for Full-Body Scanner

Key Facts

1Butterfly Network announced that Midjourney Medical's scanner prototype incorporates 40 Butterfly Ultrasound-on-Chip imaging modules.

In a move that underscores the growing integration of semiconductor technology in healthcare, Butterfly Network has partnered with Midjourney Medical to develop a novel full-body scanner. The prototype scanner incorporates 40 of Butterfly's proprietary Ultrasound-on-Chip imaging modules, marking a significant application of its semiconductor-based technology. This collaboration is part of a co-development agreement where Midjourney licenses Butterfly’s hardware for its next-generation tomographic imaging machines.

This partnership serves as a validation of Butterfly's chip technology in third-party hardware, positioning it against industry incumbents like GE HealthCare. Per market data, the shift toward silicon-based ultrasound solutions offers potential cost reductions and portability advantages over traditional piezoelectric systems. Recent industry trends highlight an increasing reliance on AI-driven diagnostic tools, a sector where Butterfly's digital platform seeks to capture a larger market share.

Regarding market performance, BFLY shares stood at $5.71 (at close June 17, 2026), having reached a high of $6.14 during the session. Investors are looking for signs of commercial scale-up and licensing revenue growth from this collaboration. Looking ahead, broader market sentiment remains influenced by recent data such as the Michigan Consumer Sentiment index, which reported a reading of 48.9 on June 12, 2026, reflecting the cautious macroeconomic backdrop for growth-stage healthtech firms.